Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Seattle, Washington 98105


Purpose:

This study is being conducted to evaluate the impact of a 28-day oral contraceptive compared to two 28-day oral contraceptive regimens containing different synthetic progestins on ovarian follicular activity and hormone levels in healthy women.


Criteria:

Inclusion Criteria: - Premenopausal, non-pregnant, non-lactating women age 18-35 years old - Body Mass Index (BMI) ≥18 kg/m² and <30 kg/m² - Regular spontaneous menstrual cycle - Others as dictated by Food and Drug Administration (FDA)-approved protocol Exclusion Criteria: - Any condition which contraindicates the use of combination oral contraceptives - Known thrombophlebitis or thromboembolic disorders; known or suspected clotting disorders; thrombogenic valvulopathies or rhythm disorders - Migraine headaches with focal, neurological symptoms - Others as dictated by FDA-approved protocol


NCT ID:

NCT01291004


Primary Contact:

Study Chair
Teva Women's Health Research Protocol Chair
Teva Branded Pharmaceutical Products, R&D Inc.


Backup Contact:

N/A


Location Contact:

Seattle, Washington 98105
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.